Our results extend initial observations of an approximate tenfold increase in expression of hepatic CCL20 transcript levels in eight samples from patients with NASH [31] to a large cohort of patients with extreme obesity. This evidence concerns the gene CCL20 and metabolic dysfunction-associated steatohepatitis.